📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator (2019)

First Author: Athukoralage J

Attributed to: Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/582114

Publication URI: http://dx.doi.org/10.1101/582114

Type: Preprint